Coverage dated November 28, 2021 to November 30, 2021

Pfizer seeks US booster OK for kids aged 16-17

Headline from FOX 61 Hartford, on the newest of 2 developments

Authorization for 16- and 17-year-olds to get Pfizer's COVID-19 vaccine booster is expected to be considered rapidly by the FDA.

FOX 61 Hartford's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Developments in this update

2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.

  1. Pfizer expected to seek FDA authorization for boosters for those ages 16 and 17

    Headline from KVOA Tucson ·

  2. Newest

    Pfizer seeks US booster OK for kids aged 16-17

    Headline from FOX 61 Hartford ·

Reports & sources

43 articles, oldest first.

  1. CNN

    Pfizer expected to seek FDA authorization for boosters for those ages 16 and 17 (opens CNN)

    Published

    CNN's feed description

    The US, European Union, Japan and other major destinations have moved to block flights from African countries following the discovery of a newly identified coronavirus variant Omicron. Follow for the latest news updates.

  2. Washington Post

    Pfizer poised to request authorization for coronavirus booster for 16 and 17 year olds (opens Washington Post)

    Published

    Washington Post's feed description

    At a time when President Biden is exhorting Americans to get coronavirus vaccine booster shots to increase protection against both delta and omicron variants, another age group might soon become eligible for the extra dose: 16- and 17-year-olds, according to two people familiar with the situation.

  3. CBS 8 San Diego

    Reports: Pfizer to seek COVID vaccine booster authorization for ages 16-17 (opens CBS 8 San Diego)

    Published

    CBS 8 San Diego's feed description

    Authorization for 16- and 17-year-olds to get Pfizer's COVID-19 vaccine booster is expected to come quickly, according to two reports.

  4. NBC10 Philadelphia

    Pfizer to Seek Approval for COVID Booster for Teens 16 and 17 (opens NBC10 Philadelphia)

    Published

    NBC10 Philadelphia's feed description

    Pfizer is expected to seek authorization this week for a COVID-19 vaccine booster for teens 16 and 17 years old, a source familiar with the process told NBC News on Monday. If approved, the additional Pfizer-BioNTech shot would mark the first vaccine booster for teens younger than 18.

  5. Tucson

    Live updates: Pfizer seeks US booster OK for kids aged 16-17 (opens Tucson)

    Published

    Tucson's feed description

    NEW YORK — Pfizer asked U.S. regulators Tuesday to allow 16- and 17-year-olds to get booster doses of its COVID-19 vaccine.

  6. KVIA El Paso

    Pfizer to ask FDA to OK boosters for all 16+ as CDC strengthens guidance (opens KVIA El Paso)

    Published

    KVIA El Paso's feed description

    WASHINGTON, DC -- Pfizer is going to ask the Food and Drug Administration in the coming days to authorize Covid-19 booster shots for 16- and 17-year-olds, a source familiar with the discussions confirmed to ABC News. This would expand booster access from everyone over 18 to everyone over 16.

  7. NBC News

    Pfizer to seek authorization for Covid booster for teens 16 and 17 (opens NBC News)

    Published

    NBC News's feed description

    Pfizer is expected to seek authorization this week for a Covid-19 vaccine booster for teenagers 16 and 17 years old, a source familiar with the process said Mon

  8. Forbes

    Pfizer Reportedly Plans To Ask For Approval Of Covid Boosters For 16- And 17-Year-Olds (opens Forbes)

    Published

    Forbes's feed description

    The report comes as public health experts track the coronavirus’ new omicron variant.

  9. MedicalXpress

    Pfizer to seek FDA approval of boosters for teens ages 16-17 (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    (HealthDay)—Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17.

  10. FOX Business

    FDA moving to authorize Pfizer-BioNTech booster for 16-, 17-year-olds (opens FOX Business)

    Published

    FOX Business's feed description

    The Food and Drug Administration could authorize Covid-19 boosters from Pfizer Inc. PFE -2.96% and BioNTech SE BNTX 4.17% for use in 16- and 17-year olds as soon as next week as concerns rise over a new, possibly more transmissible variant, according to a person familiar with the planning.

  11. WNYT Albany

    Pfizer seeks booster approval for 16 and 17-year-olds (opens WNYT Albany)

    Published

    WNYT Albany's feed description

    Pfizer is expected to seek approval for its COVID-19 vaccine booster for teenagers.

  12. The Hill

    Pfizer to apply for COVID-19 booster approval for 16- and 17-year-olds: report (opens The Hill)

    Published

    The Hill's feed description

    Pfizer and BioNTech are reportedly set to seek approval for booster shots of their COVID-19 vaccine for 16- and 17-year-olds.

  13. FOX 61 Hartford

    Pfizer seeks US booster OK for kids aged 16-17 (opens FOX 61 Hartford)

    Published

    FOX 61 Hartford's feed description

    Authorization for 16- and 17-year-olds to get Pfizer's COVID-19 vaccine booster is expected to be considered rapidly by the FDA.

  14. The Hill

    Pfizer requests authorization for booster shots in teens aged 16 and 17 (opens The Hill)

    Published

    The Hill's feed description

    Pfizer on Tuesday said the company and its partner BioNTech submitted a request to expand authorization of its coronavirus booster shot for teens aged 16 and 17

  15. Delaware Public Media

    Pfizer wants the FDA to let 16- and 17- year-olds get a COVID-19 booster shot (opens Delaware Public Media)

    Published

    Delaware Public Media's feed description

    Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Pfizer seeks US booster OK for kids aged 16-17 | Since Then